Provided by Tiger Trade Technology Pte. Ltd.

Pfizer

28.28
+0.46001.65%
Post-market: 28.27-0.0133-0.05%19:59 EDT
Volume:23.20M
Turnover:652.11M
Market Cap:160.79B
PE:37.22
High:28.29
Open:27.61
Low:27.59
Close:27.82
52wk High:29.21
52wk Low:23.62
Shares:5.69B
Float Shares:5.64B
Volume Ratio:0.69
T/O Rate:0.41%
Dividend:1.72
Dividend Rate:6.08%
EPS(TTM):0.7599
EPS(LYR):1.36
ROE:5.01%
ROA:5.78%
PB:1.89
PE(LYR):20.73

Loading ...

Pfizer Inc. Stock Underperforms Friday When Compared to Competitors Despite Daily Gains

Dow Jones
·
4 hours ago

Pfizer’s New RSV Vaccine Trial Targets Older Adults, Signaling Long-Term Growth Potential

TIPRANKS
·
8 hours ago

Pfizer’s New Asthma Bet: Tilrekimig Phase 3 Trial Moves Forward

TIPRANKS
·
8 hours ago

5%, Really? the Stock Market's Sudden High-Yielders.

Dow Jones
·
Yesterday

BofA Securities Adjusts Pfizer Price Target to $29 From $27, Maintains Neutral Rating

MT Newswires Live
·
Yesterday

J.P. Morgan Keeps Their Hold Rating on Pfizer (PFE)

TIPRANKS
·
Yesterday

An AI Transformation That Finally Let Pfizer CEO Albert Bourla Sleep Soundly

Deep News
·
Yesterday

Pfizer Limited Confirms SEBI Compliance on Share Dematerialization for Q3 2026

TIPRANKS
·
Yesterday

Pfizer price target raised to $29 from $27 at BofA

TIPRANKS
·
Yesterday

Pidilite Industries Names CFO Designate

MT Newswires Live
·
Yesterday

NYSE Most Active Issues

Dow Jones
·
Yesterday

DBS Keeps Their Buy Rating on Pfizer (PFE)

TIPRANKS
·
Yesterday

Pfizer’s VESPER-OSA 1 Trial Targets Sleep Apnea and Obesity With Monthly Shot

TIPRANKS
·
Yesterday

Pfizer (PFE) Receives a Buy from Jefferies

TIPRANKS
·
Yesterday

Cboe data shows mixed options sentiment in Pfizer with shares down 1.38%

TIPRANKS
·
Oct 08

Pfizer : Jefferies Raises Target Price to $36 from $35

THOMSON REUTERS
·
Oct 08

Cantor Fitzgerald Adjusts Price Target on Pfizer to $28 From $27

MT Newswires Live
·
Oct 08

Pfizer is Maintained at Neutral by Cantor Fitzgerald

Dow Jones
·
Oct 08

Pfizer to Cut Hundreds of Jobs at Italian Plant in Major Multinational Layoff

Deep News
·
Oct 08

FDA Greenlights Pfizer's Tukysa for First-Line Breast Cancer Indication

Stock News
·
Oct 08